Mark Adelman, MD

Chief Medical Officer

Dr. Mark Adelman is renowned globally for his clinical and academic accomplishments as a vascular surgeon. He has served as a principal investigator and DSMB/CEC chair for several landmark trials. He is a leader in many prestigious surgical societies and has authored over 130 peer-reviewed manuscripts. He is recognized as an innovator in endovascular treatment of venous, carotid, and aortic diseases, and has worked in close collaboration with the industry, the FDA, and clinicians worldwide.

Dr. Adelman previously served as Professor, Chief of Vascular and Endovascular Surgery, and Vice Chairman of Strategy and Business Development for the Department of Surgery at New York University Langone Medical Center.

The addition of Dr. Adelman to the Syntactx team has further strengthened our ability to provide the leadership and expertise in complex clinical research that clients expect from a CRO.

More People

James Lujan

Chief Technology Officer,
Syntactx Technologies

Dorothy Abel

Vice President, Regulatory Strategy

Stefaan Van der Meulen

Managing Partner,
Syntactx Europe